ADAR1 Capital Management »

Absci Corp shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Absci Corp (ABSI) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Absci Corp

Tip: Access up to 7 years of quarterly data

All positions including Absci Corp held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Absci Corp by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.3M 587k 5.68

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Absci Corp

FMR
Redmile Group
Fred Alger Management
Vanguard Group
ARK Investment Management
Millennium Management
Marshall Wace
Woodline Partners
Laurion Capital Management
Casdin Capital
Susquehanna International
BlackRock
Platinum Investment Mangement
Qube Research & Technologies
Goldman Sachs Group

View all funds holding Absci Corp